101 related articles for article (PubMed ID: 15681302)
1. Adverse associations between CX3CR1 polymorphisms and risk of cardiovascular or cerebrovascular disease.
Lavergne E; Labreuche J; Daoudi M; Debré P; Cambien F; Deterre P; Amarenco P; Combadière C;
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):847-53. PubMed ID: 15681302
[TBL] [Abstract][Full Text] [Related]
2. Association of polymorphisms in the chemokine receptor CX3CR1 gene with coronary artery disease.
Matzhold EM; Trummer O; Grünbacher G; Zulus B; Boehm BO; März W; Renner W
Cytokine; 2009 Sep; 47(3):224-7. PubMed ID: 19628406
[TBL] [Abstract][Full Text] [Related]
3. Common CX3CR1 alleles are associated with a reduced risk of headaches.
Combadière C; Godin O; Vidal C; Cangialosi A; Proust C; Tzourio C
Headache; 2008 Jul; 48(7):1061-6. PubMed ID: 18194290
[TBL] [Abstract][Full Text] [Related]
4. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
[TBL] [Abstract][Full Text] [Related]
5. Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
Niessner A; Marculescu R; Haschemi A; Endler G; Zorn G; Weyand CM; Maurer G; Mannhalter C; Wojta J; Wagner O; Huber K
Thromb Haemost; 2005 May; 93(5):949-54. PubMed ID: 15886814
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
[TBL] [Abstract][Full Text] [Related]
7. T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease.
Hattori H; Ito D; Tanahashi N; Murata M; Saito I; Watanabe K; Suzuki N
Neurosci Lett; 2005 Feb; 374(2):132-5. PubMed ID: 15644279
[TBL] [Abstract][Full Text] [Related]
8. The CX3CL1-CX3CR1 system and psoriasis.
Plant D; Young HS; Watson RE; Worthington J; Griffiths CE
Exp Dermatol; 2006 Nov; 15(11):900-3. PubMed ID: 17002687
[TBL] [Abstract][Full Text] [Related]
9. Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease.
Apostolakis S; Baritaki S; Kochiadakis GE; Igoumenidis NE; Panutsopulos D; Spandidos DA
Thromb Res; 2007; 119(1):63-71. PubMed ID: 16480760
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in CX3CR1 predict HIV-1 disease progression in children independently of CD4+ lymphocyte count and HIV-1 RNA load.
Singh KK; Hughes MD; Chen J; Spector SA
J Infect Dis; 2005 Jun; 191(11):1971-80. PubMed ID: 15871132
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between the functional CX3CR1 polymorphism V249I and hepatocellular carcinoma.
Mühlbauer M; Ringel S; Hartmann A; Lallinger G; Weiss TS; Gäbele E; Wünsch PH; Schölmerich J; Hellerbrand C
Oncol Rep; 2005 May; 13(5):957-63. PubMed ID: 15809764
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma.
Rodero M; Marie Y; Coudert M; Blondet E; Mokhtari K; Rousseau A; Raoul W; Carpentier C; Sennlaub F; Deterre P; Delattre JY; Debré P; Sanson M; Combadière C
J Clin Oncol; 2008 Dec; 26(36):5957-64. PubMed ID: 19001328
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of the fractalkine receptor CX3CR1 and systemic sclerosis-associated pulmonary arterial hypertension.
Marasini B; Cossutta R; Selmi C; Pozzi MR; Gardinali M; Massarotti M; Erario M; Battaglioli L; Biondi ML
Clin Dev Immunol; 2005 Dec; 12(4):275-9. PubMed ID: 16584113
[TBL] [Abstract][Full Text] [Related]
14. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy.
Damås JK; Boullier A; Waehre T; Smith C; Sandberg WJ; Green S; Aukrust P; Quehenberger O
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2567-72. PubMed ID: 16224053
[TBL] [Abstract][Full Text] [Related]
15. Association study between the CX3CR1 gene and asthma.
Tremblay K; Lemire M; Provost V; Pastinen T; Renaud Y; Sandford AJ; Laviolette M; Hudson TJ; Laprise C
Genes Immun; 2006 Dec; 7(8):632-9. PubMed ID: 17082760
[TBL] [Abstract][Full Text] [Related]
16. Relationship of apoE polymorphism with lipoprotein(a), apoA, apoB and lipid levels in atherosclerotic infarct.
Tascilar N; Dursun A; Ankarali H; Mungan G; Sumbuloglu V; Ekem S; Bozdogan S; Baris S; Aciman E; Cabuk F
J Neurol Sci; 2009 Feb; 277(1-2):17-21. PubMed ID: 18945448
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between a common polymorphism near the INSIG2 gene and BMI, myocardial infarction, and cardiovascular risk factors.
Wiedmann S; Neureuther K; Stark K; Reinhard W; Kallmünzer B; Baessler A; Fischer M; Linsel-Nitschke P; Erdmann J; Schunkert H; Hengstenberg C
Obesity (Silver Spring); 2009 Jul; 17(7):1390-5. PubMed ID: 19197259
[TBL] [Abstract][Full Text] [Related]
18. Beta2-adrenergic receptor gene polymorphisms and risk of ischemic stroke.
Stanzione R; Di Angelantonio E; Evangelista A; Barbato D; Marchitti S; Zanda B; Pirisi A; Quarta G; Volpe M; Rubattu S
Am J Hypertens; 2007 Jun; 20(6):657-62. PubMed ID: 17531924
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation.
Bjerkeli V; Damås JK; Fevang B; Holter JC; Aukrust P; Frøland SS
Rheumatology (Oxford); 2007 Sep; 46(9):1422-7. PubMed ID: 17616549
[TBL] [Abstract][Full Text] [Related]
20. T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis.
Amanatidou V; Sourvinos G; Apostolakis S; Tsilimigaki A; Spandidos DA
Pediatr Infect Dis J; 2006 May; 25(5):410-4. PubMed ID: 16645504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
